###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
APOE polymorphism and its effect on plasma C-reactive protein levels in a large general population sample
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Abstract
###end title 2
###begin p 3
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 549 570 549 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;4</italic>
###xml 575 591 563 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4&#949;3</italic>
###xml 695 716 671 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 936 974 900 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;3/&#949;4&#949;4</italic>
###xml 1034 1035 974 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1070 1074 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1311 1315 1251 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 741 753 <span type="species:ncbi:9606">participants</span>
###xml 789 792 <span type="species:ncbi:9606">men</span>
###xml 827 832 <span type="species:ncbi:9606">women</span>
The published data remain inconsistent on association between apolipoprotein E (APOE) gene variations and plasma levels of C-reactive protein (CRP), mainly because of low statistical power of previous studies. To clarify this question, we analyzed data from large population sample of randomly selected individuals from seven Czech towns (2,886 males and 3,344 females, the HAPIEE [Health, Alcohol, and Psychosocial factors In Eastern Europe] study). In both males and females, the lowest levels of plasma hsCRP were observed in the carriers of the APOE epsilon4epsilon4 and epsilon4epsilon3 genotypes. The median (interquartile range, IQR) concentration of hsCRP in carriers of the most common APOE epsilon3epsilon3 genotype (two-thirds of participants) was 1.13 mg/l (IQR, 0.56-2.33) in men and 1.23 mg/l (IQR, 0.61-2.65) in women, compared with 0.72 mg/l (IQR, 0.61-0.86) in male and 0.72 mg/l (IQR, 0.61-0.85) in female carriers of APOE epsilon4epsilon3/epsilon4epsilon4 genotypes; the differences were statistically significant (p < 0.001). The association between APOE and CRP was not materially affected by adjustment for age, sex, history of cardiovascular disease, or cardiovascular risk factors. This study, the largest to date, provides robust evidence of an association between plasma hsCRP and the APOE genotype, an association not explained by history of cardiovascular disease nor its risk factors.
###end p 3
###begin title 4
Keywords
###end title 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 143 146 143 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr">[1]</xref>
###xml 482 487 482 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2 bib3" ref-type="bibr">[2,3]</xref>
###xml 568 571 568 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr">[4]</xref>
###xml 748 751 748 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr">[5]</xref>
###xml 875 880 875 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6 bib7 bib8 bib9" ref-type="bibr">[6&#8211;9]</xref>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
There is extensive published data on the potential effect of low-grade inflammation in the vascular endothelium on atherosclerosis development [1]. C-reactive protein (CRP), the acute phase serum protein produced by liver, has often been used as an overall marker of inflammation. Elevated plasma levels of CRP have been repeatedly found in patients with cardiovascular disease (CVD) and myocardial infarction, and it has been proposed that CRP is an independent risk factor of CVD [2,3], although the pathogenic and clinical significance of CRP remains controversial [4]. In addition to CVD, plasma levels of CRP have been also found to correlate with CVD risk factors, such as body mass index (BMI), lipid parameters, smoking, and dietary habits [5]. Similarly to other risk factors of atherosclerosis development, plasma levels of CRP are partially genetically determined [6-9].
###end p 6
###begin p 7
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 227 231 227 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 248 249 242 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</italic>
###xml 251 259 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 265 273 253 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 381 388 363 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11 bib12 bib13" ref-type="bibr">[10&#8211;13]</xref>
###xml 427 435 409 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;4</italic>
###xml 532 540 506 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2</italic>
###xml 632 648 598 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3&#949;3</italic>
###xml 710 714 664 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 774 778 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 879 886 833 840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14 bib15" ref-type="bibr">[14,15]</xref>
###xml 1001 1014 955 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 1022 1026 970 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 1098 1102 1046 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr">[16]</xref>
###xml 511 518 <span type="species:ncbi:9606">persons</span>
###xml 872 878 <span type="species:ncbi:9606">humans</span>
###xml 1089 1097 <span type="species:ncbi:9606">patients</span>
Apolipoprotein E (APOE, gene ID 348, OMIM acc Number 107741) is a multifunctional protein that plays a key role in the metabolism of plasma lipids and is found on the surface of the triglyceride rich lipoproteins. Three common APOE alleles (epsilon2, epsilon3, and epsilon4) and many rare mutations have been described; the frequencies of these variants differ between populations [10-13]. In general, individuals carrying the epsilon4 allele [Cys112 --> Arg, rs429358] have higher total cholesterol levels and persons carrying the epsilon2 allele [Arg158 --> Cys, rs7412] have lower cholesterol than those carrying the most common epsilon3epsilon3 genotype. The role of the apolipoprotein E, regulated by the APOE gene, in the inflammatory response has also been suggested [14], and there is some evidence to support such an effect from studies in both animal models and humans [14,15]. Although data on individual variants are not entirely consistent, a pro-inflammatory state seems associated with APOE epsilon4 allele [14]; the same allele is associated with severe sepsis in surgical patients [16].
###end p 7
###begin p 8
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 271 287 271 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3/e3</italic>
###xml 322 338 316 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4/e4</italic>
###xml 343 359 331 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4/e2</italic>
###xml 369 373 351 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr">[17]</xref>
###xml 436 443 418 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table 1</xref>
###xml 443 450 425 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18 bib19 bib20 bib21 bib22 bib23 bib24 bib25 bib26 bib27 bib28 bib29 bib30 bib31 bib32 bib33 bib34 bib35" ref-type="bibr">[18&#8211;35]</xref>
###xml 621 625 603 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">e.g.</italic>
###xml 761 765 743 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 893 897 875 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 970 974 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1057 1061 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1192 1196 1174 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1250 1254 1232 1236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr">[36]</xref>
###xml 1296 1300 1278 1282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1331 1335 1313 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 627 635 <span type="species:ncbi:9606">patients</span>
A possible, but physiologically unexplained, association has been suggested between the common APOE polymorphism and plasma level of CRP. However, the results to date are contradictory. Although initial observations suggested that the highest plasma levels of CRP are in APOE epsilon3/e3 carriers and the lowest levels in APOE epsilon4/e4 and APOE epsilon4/e2 carriers [17], subsequent studies were not entirely consistent, as shown in Table 1[18-35]. A large part of the apparent inconsistencies is due to the very low statistical power of most studies (with a few exceptions), the use of various preselected subgroups (e.g., patients with dyslipidemias or CVD, diabetics, or elderly subjects) and unclear methodology. Clarification of the association between APOE genotype and CRP is important for at least two reasons. First, the biologic mechanisms responsible for the association between APOE genotype and CVD remain unclear; examining whether associations between APOE and potential cardiovascular risk factors (such as CRP) mirror the association of APOE with CVD is, therefore, helpful in elucidating the causal pathway. Second, it has long been recognized that apolipoprotein E, and APOE genotype, affect a broad range of biologic functions [36], and there is interest in the effects of APOE on inflammatory response rate [14].
###end p 8
###begin p 9
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
In this article, we used data from a large population-based study with sufficient statistical power, to investigate differences in plasma CRP levels by APOE genotype, and whether such differences can be explained by history of CVD or its risk factors.
###end p 9
###begin title 10
Subjects and methods
###end title 10
###begin title 11
Study subjects
###end title 11
###begin p 12
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr">[37]</xref>
###xml 211 214 <span type="species:ncbi:9606">men</span>
###xml 219 224 <span type="species:ncbi:9606">women</span>
###xml 448 455 <span type="species:ncbi:9606">persons</span>
We used data from the Czech part of the HAPIEE (Health, Alcohol, and Psychosocial factors In Eastern Europe) study. Details of the study have been described elsewhere [37]. Briefly, random population samples of men and women aged 45-69 years from seven Czech towns (Jihlava, Havirov, Hradec Kralove, Karvina, Kromeriz, Liberec, and Usti nad Labem) were invited to complete a questionnaire and to attend an examination in a clinic. A total of 8,856 persons completed the questionnaire (response rate: 55%), of whom 7,260 attended the examination, 6,920 provided blood sample, and DNA sample was available on 6,748 individuals.
###end p 12
###begin title 13
Measurements
###end title 13
###begin p 14
###xml 317 321 317 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr">[38]</xref>
###xml 341 345 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 389 393 389 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr">[39]</xref>
###xml 490 494 490 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr">[11]</xref>
###xml 581 582 581 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 725 729 725 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr">[40]</xref>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 603 606 <span type="species:ncbi:9606">men</span>
###xml 616 621 <span type="species:ncbi:9606">women</span>
###xml 881 888 <span type="species:ncbi:9606">persons</span>
High-sensitivity (hs) CRP was measured immunoturbidimetrically by the WHO Lipid Reference Centre in Prague, using the Roche COBAS (Mannheim, Germany), MIRA autoanalyzer and reagents from Orion Diagnostica, Espoo, Finland (kit no. 68025). DNA was isolated from frozen whole blood using the standard salting-out method [38]. Genotyping of the APOE gene was performed as described previously [39]. The frequencies of the individual genotypes are similar to findings in neighboring populations [11], and deviation from the Hardy-Weinberg equilibrium was not statistically significant (p-values were 0.13 in men, 0.22 in women, and 0.07 in both genders combined). In seven individuals, a rare APOE mutation Arg136Cys was detected [40], and these individuals were excluded from the study. In further 73 individuals, the genotyping failed even when repeated three times. A total of 6,492 persons had valid data, both on CRP level and APOE genotype.
###end p 14
###begin title 15
Statistical analyses
###end title 15
###begin p 16
###xml 67 68 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 245 249 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
We further excluded subjects who had hsCRP >/= 10 mg/l CRP levels (n = 262) from the analysis because of a possible acute infection. The present analyses are thus based on 6,230 subjects (2,886 males and 3,344 females) with full data on CRP and APOE and with hsCRP concentrations <10 mg/l.
###end p 16
###begin p 17
###xml 213 217 213 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 360 364 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 616 620 616 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 991 992 991 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1441 1442 1439 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 445 448 <span type="species:ncbi:9606">men</span>
###xml 453 458 <span type="species:ncbi:9606">women</span>
###xml 536 539 <span type="species:ncbi:9606">men</span>
###xml 544 549 <span type="species:ncbi:9606">women</span>
Because the distribution of hsCRP levels is highly skewed, to the extent that even logarithmically transformed values are highly asymmetrically distributed, we used nonparametric methods. First, we show, for each APOE genotype, and within each sex, the median and interquartile range (IQR) of hsCRP concentrations. Second, crude differences in hsCRP levels by APOE genotype were assessed by the Kruskal-Wallis nonparametric test, separately for men and women. Finally, because the differences in hsCRP by APOE genotypes were similar in men and women, data from both genders were pooled, and the relationship between APOE genotype and quartile of hsCRP was estimated using ordered logistic regression. This approach, while not making assumption about the distribution of CRP, allows multivariate analysis and therefore adjustment for covariates; we controlled for age, sex, history of myocardial infarction, angina and stroke (each coded as 0/1), current smoking, total cholesterol, BMI (kg/m2), and hypertension (systolic/diastolic blood pressure >/=140/85 mm Hg or antihypertensive medication in the last 2 weeks). The odds ratio derived from ordered logistic regression can be interpreted as the weighted mean of (i) odds of CRP quartile 1 vs. quartiles 2-4, (ii) odds of quartiles 1-2 vs. quartiles 3-4, and (iii) odds of quartiles 1-3 vs. quartile 4, associated with a given genotype. The proportional odds assumption was fulfilled (the p-value from the approximate likelihood-ratio test of proportionality of odds across CRP quartile response categories was 0.133).
###end p 17
###begin title 18
Results
###end title 18
###begin p 19
###xml 87 94 87 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table 2</xref>
###xml 161 162 161 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 416 437 416 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2&#949;2</italic>
###xml 444 465 432 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2&#949;3</italic>
###xml 473 494 449 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 502 523 466 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;3</italic>
###xml 531 552 483 492 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;2</italic>
###xml 563 584 503 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;4</italic>
###xml 142 145 <span type="species:ncbi:9606">men</span>
###xml 154 159 <span type="species:ncbi:9606">women</span>
Descriptive characteristics of the subjects included in the analysis are summarized in Table 2. The median CRP levels were slightly higher in men than in women (p < 0.001) and, as expected, CRP was positively correlated with age, BMI, and smoking (not shown in table). The distribution of the APOE genotypes in individuals excluded because of CRP concentration > =10 mg/l did not differ from the general population (APOE epsilon2epsilon2 0.8%, APOE epsilon2epsilon3 13.7%, APOE epsilon3epsilon3 65.3%, APOE epsilon4epsilon3 16.8%, APOE epsilon4epsilon2 2.7%, and APOE epsilon4epsilon4 0.8%, not shown in table).
###end p 19
###begin p 20
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 64 71 64 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl3" ref-type="table">Table 3</xref>
###xml 133 137 133 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 236 240 236 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 275 288 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 297 318 291 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 336 349 318 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 364 385 340 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2&#949;4</italic>
###xml 560 581 524 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 654 675 606 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 741 762 681 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;2</italic>
The plasma levels hsCRP by the APOE genotypes are summarized in Table 3. Serum levels of hsCRP differed highly significantly between APOE genotypes, both by all six individual genotypes and by four groups defined by the presence of the APOE alleles, that is, carriers of the APOE epsilon2 allele, APOE epsilon3epsilon3 homozygotes, and APOE epsilon4 carriers. The APOE epsilon2epsilon4 genotype is also reported separately because of the uncertainty about pooling with other genotypes. The differences were of similar magnitude in males and females. In males, APOE epsilon3epsilon3 homozygotes had the highest median serum hsCRP; similarly, females with APOE epsilon3epsilon3 genotype also had high CRP (only very slightly lower median than APOE epsilon4epsilon2 heterozygotes); even in such a large study, however, the numbers of individuals with specific uncommon genotypes within each sex were insufficient to provide statistically reliable estimates of hsCRP levels.
###end p 20
###begin p 21
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 304 311 304 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl4" ref-type="table">Table 4</xref>
###xml 524 537 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 550 571 544 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;3</italic>
###xml 576 597 558 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4&#949;4</italic>
###xml 653 674 623 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;3&#949;3</italic>
###xml 40 43 <span type="species:ncbi:9606">men</span>
###xml 48 53 <span type="species:ncbi:9606">women</span>
Given the similarity of associations in men and women (and the interactions between sex and APOE were not statistically significant), we pooled the data from both genders, and we used ordered logistic regression to assess the association between APOE genotype and hsCRP after controlling for covariates (Table 4). The associations remained strong and highly statistically significant after adjustment for the age, history of CVD, smoking, BMI, total cholesterol, and hypertension. In addition to lower hsCRP in the combined APOE epsilon4 group, both APOE epsilon4epsilon3 and APOE epsilon4epsilon4 genotypes had statistically lower levels of hsCRP than APOE epsilon3epsilon3 homozygotes in these pooled analyses (because of increased statistical power, compared with sex-specific analyses).
###end p 21
###begin title 22
Discussion
###end title 22
###begin p 23
###xml 158 162 158 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 289 302 289 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
The present study, the largest on this subject to date, found that the serum hsCRP is independently determined by the common genetic polymorphisms within the APOE gene. Given the large size (and hence, high statistical power) of this study, these findings provide robust evidence that the APOE epsilon4 allele is associated with low levels of plasma hsCRP.
###end p 23
###begin p 24
###xml 116 124 116 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;2</italic>
###xml 129 137 123 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#949;3</italic>
###xml 185 192 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib18" ref-type="bibr">[17,18]</xref>
###xml 270 283 258 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 293 300 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib21" ref-type="bibr">[19,21]</xref>
###xml 317 321 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 352 356 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr">[22]</xref>
###xml 441 454 423 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 462 466 438 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr">[23]</xref>
###xml 562 566 538 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 699 702 675 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr">[8]</xref>
Previous studies on this subject did not yield results that were not entirely consistent. In some populations, both epsilon2 and epsilon3 carriers were reported to have the highest CRP [17,18]. Some studies of elderly subjects showed either the highest levels of CRP in APOE epsilon2 carriers [19,21] or no effect of APOE genotype on plasma CRP at all [22]. A study in younger adult females found the highest hsCRP levels in carriers of the APOE epsilon4 allele [23]. In a recent genome-wide association study, CRP levels had a significant genetic component and APOE was among genes detected to have a significant effect on plasma CRP; however, CRP values by the specific alleles were not available [8].
###end p 24
###begin p 25
###xml 242 252 242 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17 bib21 bib27" ref-type="bibr">[17,21,27]</xref>
###xml 291 295 291 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr">[20]</xref>
###xml 309 316 309 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19 bib22" ref-type="bibr">[19,22]</xref>
###xml 342 349 342 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24 bib26" ref-type="bibr">[24,26]</xref>
###xml 583 587 583 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 166 173 <span type="species:ncbi:9606">patient</span>
###xml 333 341 <span type="species:ncbi:9606">patients</span>
The discrepancies in previous findings are mainly due to the low statistical power of most previous studies. In addition, many studies analyzed subjects who included patient's relatives or preselected subgroups, such as dyslipidemic subjects [17,21,27], ethnically nonhomogenous populations [20], the elderly [19,22], or families of patients [24,26]. There were also methodological inconsistencies; for example, many papers do not specify whether extreme hsCRP levels were excluded from the analyses (because of the concerns about the presence of acute infection) or the grouping of APOE genotypes differs between papers. Inappropriate statistics may have also contributed to the heterogeneous findings-most studies reported geometrical means of hsCRP but, given the extremely skewed distribution of hsCRP, the use of parametric methods is likely to produce misleading results. Overall, previous data mostly suggest low CRP levels in carriers of epsilon4 compared with epsilon3epsilon3, but the inconsistencies in reporting allow neither reliable conclusions nor formal meta-analysis without obtaining the raw data.
###end p 25
###begin p 26
###xml 1141 1145 1141 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 392 400 <span type="species:ncbi:9606">patients</span>
Our study overcame many of these limitations. First, its size (roughly equivalent to half of all previous published studies combined) provided sufficient statistical power to study not only groups of genotypes, but specific genotypes separately. Second, contrary to many previous investigations, our study recruited a random general (and ethnically homogenous) population sample, rather than patients selected for a particular condition, such as candidates for statin treatment, diabetics, or different ethnicities. Third, our study sample was slightly younger than many previous studies (the mean age in many studies was considerably higher than sixty years); as age is an important predictor of CRP, studies in younger subjects are particularly useful. Fourth, we excluded subjects with high CRP levels, and thus limited misclassification because of possible acute infection, and used nonparametric methods that do not make assumptions about distribution of CRP. Finally, our subjects were phenotypically well characterized, enabling us to discount history of CVD and risk factors for CVD as possible explanations for the relation between APOE genotype and hsCRP.
###end p 26
###begin p 27
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
The biologic basis for the relationship between APOE and hsCRP is not clear. Given that both plasma apolipoprotein E and CRP come from the same source in organism, the liver, the expression of these proteins could be regulated by similar factors, but no experimental evidence has been published so far.
###end p 27
###begin p 28
###xml 319 322 319 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr">[3]</xref>
###xml 352 356 352 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr">[14]</xref>
###xml 371 384 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 454 458 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib41" ref-type="bibr">[41]</xref>
###xml 505 509 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 658 671 646 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 831 835 813 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib42" ref-type="bibr">[42]</xref>
###xml 899 912 881 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;2</italic>
###xml 935 948 911 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE &#949;4</italic>
###xml 958 962 928 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib43" ref-type="bibr">[43]</xref>
###xml 998 1002 968 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 1081 1085 1051 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
The present results, consistent with most previously published data, highlight an important contradiction. On the one hand, individuals with elevated levels of the hsCRP are at increased risk of mortality and morbidity from multiple disease states, including myocardial infarction, stroke, diabetes, metabolic syndrome [3], and end stage renal disease [14]. By contrast, APOE epsilon4 is associated with increased risk of CVD and end stage renal disease [41]. Yet, the CRP levels are lower in carriers of APOE epsilon4, which is the "risky" genotype for CVD, and high concentrations of hsCRP, proposed to be a risk factor of CVD, are not associated with the APOE epsilon4 allele as would be expected. To complicate the situation further, there is an inverse association between plasma apolipoprotein E concentration and CRP levels [42], and plasma apolipoprotein concentrations seem to be higher in APOE epsilon2 carriers and lower in APOE epsilon4 carriers [43]. This suggests that the effects of APOE and CRP operate by different and mutually independent mechanisms, or that the APOE genotype is associated with, but is not a causal determinant of plasma CRP levels.
###end p 28
###begin p 29
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib44" ref-type="bibr">[44]</xref>
It is possible that slightly elevated CRP levels, based on genetic predisposition, rather than inflammatory status, account for the elevated risk of vascular disease. Indeed, a large prospective study has shown that variants in the CRP gene are associated with marked increase of CRP levels, but these polymorphisms were not associated with increased risk of vascular disease [44]. This would allow for the possibility that adverse effects of increases in CRP levels are limited to inflammation induced environmentally, rather than genetically.
###end p 29
###begin p 30
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Our study was not designed to investigate the important question of the etiological role of CRP in CVD. However, we have clearly demonstrated that the APOE genotype influences CRP concentrations. Future studies are needed to clarify the implication of this association for the risk of common diseases, such as vascular diseases.
###end p 30
###begin title 31
Acknowledgments
###end title 31
###begin p 32
The authors thank nurses in the Czech regional Health Institutes who collected the data. This work was supported by project No. 1M0510 from the Ministry of Health, Youth and Education of the Czech Republic; grant from Institute for Clinical and Experimental Medicine (00023001); grant from the Wellcome Trust "Determinants of Cardiovascular Diseases in Eastern Europe: A multi-centre cohort study" (Reference number 064947/Z/01/Z) and "Determinants of Cardiovascular Diseases in Eastern Europe: Longitudinal follow-up of a multi-centre cohort study (The HAPIEE Project)" (Reference number 081081/Z/06/Z); a grant from the National Institute on Aging "Health disparities and aging in societies in transition (the HAPIEE study)", grant number 1R01 AG23522-01; and a grant from MacArthur Foundation "Health and Social Upheaval (a research network)".
###end p 32
###begin title 33
References
###end title 33
###begin article-title 34
Inflammation and atherosclerosis
###end article-title 34
###begin article-title 35
C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
###end article-title 35
###begin article-title 36
Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: Implications for longevity
###end article-title 36
###begin article-title 37
C-reactive protein and coronary heart disease: A critical review
###end article-title 37
###begin article-title 38
What does minor elevation of C-reactive protein signify?
###end article-title 38
###begin article-title 39
Genetic determinants of C-reactive protein
###end article-title 39
###begin article-title 40
Association of common CRP gene variants with CRP levels and cardiovascular events
###end article-title 40
###begin article-title 41
###xml 128 133 <span type="species:ncbi:9606">Women</span>
Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: The Women's Genome Health Study
###end article-title 41
###begin article-title 42
Apolipoprotein CI, and not apolipoprotein E, polymorphism affects plasma levels of C-reactive protein?
###end article-title 42
###begin article-title 43
Apolipoprotein E polymorphism and atherosclerosis
###end article-title 43
###begin article-title 44
Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world
###end article-title 44
###begin article-title 45
Apolipoprotein E gene polymorphism in the Mongolian population
###end article-title 45
###begin article-title 46
Variable expression of hypercholesterolemia in Apolipoprotein E2* (Arg136 -> Cys) heterozygotes
###end article-title 46
###begin article-title 47
Impact of apoE genotype on oxidative stress, inflammation and disease risk
###end article-title 47
###begin article-title 48
Apolipoprotein E-mediated immune regulation in sepsis
###end article-title 48
###begin article-title 49
###xml 71 79 <span type="species:ncbi:9606">patients</span>
APOE polymorphism is associated with risk of severe sepsis in surgical patients
###end article-title 49
###begin article-title 50
###xml 81 84 <span type="species:ncbi:9606">men</span>
Apolipoprotein E polymorphism and C-reactive protein in dyslipidemic middle-aged men
###end article-title 50
###begin article-title 51
The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study)
###end article-title 51
###begin article-title 52
Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians
###end article-title 52
###begin article-title 53
Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study
###end article-title 53
###begin article-title 54
Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study
###end article-title 54
###begin article-title 55
ApoE plasma levels and risk of cardiovascular mortality in old age
###end article-title 55
###begin article-title 56
###xml 87 95 <span type="species:ncbi:9606">children</span>
Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: The cardiovascular risk in Young Finns study
###end article-title 56
###begin article-title 57
Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: Association with apolipoprotein E alleles
###end article-title 57
###begin article-title 58
Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein
###end article-title 58
###begin article-title 59
ApoE polymorphism is associated with C-reactive protein in low-HDL family members and in normolipidemic subjects
###end article-title 59
###begin article-title 60
New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals
###end article-title 60
###begin article-title 61
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Apolipoprotein E genotype in dyslipidemic patients and response of blood lipids and inflammatory markers to alpha-linolenic acid
###end article-title 61
###begin article-title 62
###xml 67 75 <span type="species:ncbi:9606">patients</span>
Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease
###end article-title 62
###begin article-title 63
Apolipoprotein E e4 allele affects risk of hyperhomocysteinemia in the elderly
###end article-title 63
###begin article-title 64
C-reactive protein and rate of dementia in carriers and non carriers of apolipoprotein APOE4 genotype
###end article-title 64
###begin article-title 65
Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status
###end article-title 65
###begin article-title 66
High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: Results from the 90+ study
###end article-title 66
###begin article-title 67
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Inflammatory marker expression and its implication in Korean ischemic stroke patients
###end article-title 67
###begin article-title 68
Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans
###end article-title 68
###begin article-title 69
Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology
###end article-title 69
###begin article-title 70
Determinants of cardiovascular disease and other non-communicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study
###end article-title 70
###begin article-title 71
###xml 55 60 <span type="species:ncbi:9606">human</span>
A simple salting out procedure for extracting DNA from human nucleated cells
###end article-title 71
###begin article-title 72
###xml 25 30 <span type="species:ncbi:9606">human</span>
Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI
###end article-title 72
###begin article-title 73
Apolipoprotein E Arg136 -> Cys mutation and hyperlipidemia in a large central European population sample
###end article-title 73
###begin article-title 74
Review: Biology and relevance of C-reactive protein in cardiovascular and renal disease
###end article-title 74
###begin article-title 75
Negative and independent influence of apolipoprotein E on C-reactive protein (CRP) concentration in obese adults
###end article-title 75
###begin article-title 76
Apolipoprotein E mutants, hyperlipidemia and arteriosclerosis
###end article-title 76
###begin article-title 77
Genetically elevated C-reactive protein and ischemic vascular disease
###end article-title 77
###begin p 78
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Previous population-based studies on APOE genotype and CRP levels
###end p 78
###begin p 79
Note: Studies were identified in PubMed using the following combinations of search terms: ("apoe" or "apo e" or "apoliporotein e") and ("genotype" or "gene" or "polymorphisms") and ("crp" or "c-reactive protein").
###end p 79
###begin p 80
Basic characteristics of subjects included in the analysis
###end p 80
###begin p 81
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
Median (IQR) concentrations of CRP by APOE genotype and odds ratios (95% confidence intervals) from ordered logistic regression (with quartiles of CRP as dependent variable), by sex
###end p 81
###begin p 82
Kruskal-Wallis non-parametric test.
###end p 82
###begin p 83
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APOE</italic>
###xml 186 189 <span type="species:ncbi:9606">men</span>
###xml 194 199 <span type="species:ncbi:9606">women</span>
Crude and adjusted odds ratios (95% confidence intervals) by APOE genotype from ordered logistic regression, with quartiles of CRP concentrations as dependent variable; pooled data from men and women
###end p 83
###begin p 84
adjusted for age, sex, total cholesterol, hypertension, body mass index, smoking, and history of angina, myocardial infarction and stroke.
###end p 84

